Sage Journals: Discover world-class research

Open access

Research article

First published 2022

Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis

Laura Besendorf, Tanja M. Müller, Carol-Immanuel Geppert [...]

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2011-6

An Integrin α4β7•IgG Heterodimeric Chimera Binds to MAdCAM-1 on High Endothelial Venules in Gut-Associated Lymphoid Tissue

Hitomi Hoshino, Motohiro Kobayashi, Junya Mitoma [...]

Journal of Histochemistry & Cytochemistry

Retricted access

Research article

First published 2016-10

Vedolizumab

Mara Poulakos, Jade D. Machin, Julienne Pauly [...]

Journal of Pharmacy Practice

Free access

Review article

First published 2010-03

Review: Current directions of biologic therapies in inflammatory bowel disease

Catherine Reenaers, Edouard Louis, Jacques Belaiche

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2021

α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis

Michaela Melde, Tanja M. Müller, Ines Schneider [...]

Therapeutic Advances in Gastroenterology

Open access

Case report

First published 2022

Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab,a case report

Maria d’Apolito, Rocco Spagnuolo, Maria Anna Siciliano [...]

Sage Open Chronic Disease

Open access

Review article

First published 2019

New biologics and small molecules in inflammatory bowel disease: an update

João Sabino, Bram Verstockt, Séverine Vermeire [...]

Therapeutic Advances in Gastroenterology

Free access

Review article

First published 2016-5

The role of vedolizumab in patients with moderate-to-severe Crohn’s disease and ulcerative colitis

Neal Shahidi, Brian Bressler, Remo Panaccione

Therapeutic Advances in Gastroenterology

Free access

Review article

First published 2017-10

Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges

Marcel Vetter, Markus F. Neurath

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2020

Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements

Orla Mader, Pascal Juillerat, Luc Biedermann [...]

United European Gastroenterology Journal

Search results